1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 1994. 4th ed. Washington DC: American Psychiatric Association.
2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007. 164:942–948.
3. Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003. 2:104–113.
4. Dunn DW, Austin JK, Harezlak J, Ambrosius WT. ADHD and epilepsy in childhood. Dev Med Child Neurol. 2003. 45:50–54.
5. Szatmari P, Offord DR, Boyle MH. Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiatry. 1989. 30:219–230.
6. Caplan R, Siddarth P, Stahl L, Lanphier E, Vona P, Gurbani S, Koh S, Sankar R, Shields WD. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia. 2008. 49:1838–1846.
7. Vega C, Vestal M, DeSalvo M, Berman R, Chung M, Blumenfeld H, Spann MN. Differentiation of attention-related problems in childhood absence epilepsy. Epilepsy Behav. 2010. 19:82–85.
8. Hamoda HM, Guild DJ, Gumlak S, Travers BH, Gonzalez-Heydrich J. Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations. Expert Rev Neurother. 2009. 9:1747–1754.
9. Aman MG. Stimulant drugs in the developmental disabilities revisited. J Dev Phys Disabil. 1996. 8:347–365.
10. Pearson DA, Santos CW, Roache JD, Casat CD, Loveland KA, Lachar D, Lane DM, Faria LP, Cleveland LA. Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry. 2003. 42:209–216.
11. Roberts JE, Miranda M, Boccia M, Janes H, Tonnsen BL, Hatton DD. Treatment effects of stimulant medication in young boys with fragile X syndrome. J Neurodev Disord. 2011. 3:175–184.
12. Aman MG, Buican B, Arnold LE. Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacol. 2003. 13:29–40.
13. Hermann BP, Whitman S, Hughes JR, Melyn MM, Dell J. Multietiological determinants of psychopathology and social competence in children with epilepsy. Epilepsy Res. 1988. 2:51–60.
14. Marston D, Besag F, Binnie CD, Fowler M. Effects of transitory cognitive impairment on psychosocial functioning of children with epilepsy: a therapeutic trial. Dev Med Child Neurol. 1993. 35:574–581.
15. Bennett-Back O, Keren A, Zelnik N. Attention-deficit hyperactivity disorder in children with benign epilepsy and their siblings. Pediatr Neurol. 2011. 44:187–192.
16. Jones JE, Watson R, Sheth R, Caplan R, Koehn M, Seidenberg M, Hermann B. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol. 2007. 49:493–497.
17. Hermann B, Jones J, Dabbs K, Allen CA, Sheth R, Fine J, McMillan A, Seidenberg M. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain. 2007. 130:3135–3148.
18. Lendt M, Helmstaedter C, Kuczaty S, Schramm J, Elger CE. Behavioural disorders in children with epilepsy: early improvement after surgery. J Neurol Neurosurg Psychiatry. 2000. 69:739–744.
19. Murphy P, Burnham WM. The ketogenic diet causes a reversible decrease in activity level in Long-Evans rats. Exp Neurol. 2006. 201:84–89.
20. You SJ, Kang HC, Kim HD, Ko TS, Kim DS, Hwang YS, Kim DS, Lee JK, Park SK. Vagus nerve stimulation in intractable childhood epilepsy: a Korean multicenter experience. J Korean Med Sci. 2007. 22:442–445.